Seagen to Report Third Quarter 2023 Financial Results on November 1, 2023
12 10월 2023 - 9:00PM
Business Wire
Seagen Inc. (Nasdaq: SGEN) announced today that it will report
third quarter 2023 financial results on Wednesday, November 1,
2023.
Given the previously announced agreement to be acquired by
Pfizer Inc., Seagen will not be hosting a conference call.
About Seagen
Founded 25 years ago, Seagen Inc. is a global biotechnology
company that discovers, develops, manufactures and commercializes
targeted cancer therapeutics, with antibody-drug conjugates (ADCs)
at our core. Our colleagues work together with urgency to improve
and extend the lives of people living with cancer. An ADC
technology trailblazer, approximately one-third of FDA-approved and
marketed ADCs use Seagen technology. Seagen is headquartered in
Bothell, Washington and has locations in California, Canada,
Switzerland and across Europe. For additional information, visit
www.seagen.com and follow us on Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231012765576/en/
For Investors Douglas Maffei, Ph.D. Vice President, Investor
Relations (425) 527-4881 dmaffei@seagen.com
For Media David Caouette Vice President, Corporate
Communications (310) 430-3476 dcaouette@seagen.com
Seagen (NASDAQ:SGEN)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Seagen (NASDAQ:SGEN)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
